Blood Glucose Device Market Report

Global Blood Glucose Device Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：206
  • REPORT CODE：GMM848745
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Blood Glucose Device market report explains the definition, types, applications, major countries, and major players of the Blood Glucose Device market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson (US)

    • ARKRAY (Japan)

    • FHoffmann-La Roche Ltd (Switzerland)

    • Dexcom (US)

    • Abbott Laboratories (US)

    • Terumo Medical Corporation (US)

    • Medtronic (US)

    • Nipro Diagnostics (US)

    By Type:

    • Blood Glucose Monitors

    • Glucose Monitoring Strips

    • Lancets

    By End-User:

    • Hospitals

    • Diagnostics

    • Home Settings

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Blood Glucose Device Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Blood Glucose Device Outlook to 2028- Original Forecasts

    • 2.2 Blood Glucose Device Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Blood Glucose Device Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Blood Glucose Device Market- Recent Developments

    • 6.1 Blood Glucose Device Market News and Developments

    • 6.2 Blood Glucose Device Market Deals Landscape

    7 Blood Glucose Device Raw Materials and Cost Structure Analysis

    • 7.1 Blood Glucose Device Key Raw Materials

    • 7.2 Blood Glucose Device Price Trend of Key Raw Materials

    • 7.3 Blood Glucose Device Key Suppliers of Raw Materials

    • 7.4 Blood Glucose Device Market Concentration Rate of Raw Materials

    • 7.5 Blood Glucose Device Cost Structure Analysis

      • 7.5.1 Blood Glucose Device Raw Materials Analysis

      • 7.5.2 Blood Glucose Device Labor Cost Analysis

      • 7.5.3 Blood Glucose Device Manufacturing Expenses Analysis

    8 Global Blood Glucose Device Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Blood Glucose Device Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Blood Glucose Device Export by Region (Top 10 Countries) (2017-2028)

    9 Global Blood Glucose Device Market Outlook by Types and Applications to 2022

    • 9.1 Global Blood Glucose Device Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Glucose Monitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Glucose Monitoring Strips Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lancets Consumption and Growth Rate (2017-2022)

    • 9.2 Global Blood Glucose Device Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Settings Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Blood Glucose Device Market Analysis and Outlook till 2022

    • 10.1 Global Blood Glucose Device Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Blood Glucose Device Consumption (2017-2022)

      • 10.2.2 Canada Blood Glucose Device Consumption (2017-2022)

      • 10.2.3 Mexico Blood Glucose Device Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Blood Glucose Device Consumption (2017-2022)

      • 10.3.2 UK Blood Glucose Device Consumption (2017-2022)

      • 10.3.3 Spain Blood Glucose Device Consumption (2017-2022)

      • 10.3.4 Belgium Blood Glucose Device Consumption (2017-2022)

      • 10.3.5 France Blood Glucose Device Consumption (2017-2022)

      • 10.3.6 Italy Blood Glucose Device Consumption (2017-2022)

      • 10.3.7 Denmark Blood Glucose Device Consumption (2017-2022)

      • 10.3.8 Finland Blood Glucose Device Consumption (2017-2022)

      • 10.3.9 Norway Blood Glucose Device Consumption (2017-2022)

      • 10.3.10 Sweden Blood Glucose Device Consumption (2017-2022)

      • 10.3.11 Poland Blood Glucose Device Consumption (2017-2022)

      • 10.3.12 Russia Blood Glucose Device Consumption (2017-2022)

      • 10.3.13 Turkey Blood Glucose Device Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Blood Glucose Device Consumption (2017-2022)

      • 10.4.2 Japan Blood Glucose Device Consumption (2017-2022)

      • 10.4.3 India Blood Glucose Device Consumption (2017-2022)

      • 10.4.4 South Korea Blood Glucose Device Consumption (2017-2022)

      • 10.4.5 Pakistan Blood Glucose Device Consumption (2017-2022)

      • 10.4.6 Bangladesh Blood Glucose Device Consumption (2017-2022)

      • 10.4.7 Indonesia Blood Glucose Device Consumption (2017-2022)

      • 10.4.8 Thailand Blood Glucose Device Consumption (2017-2022)

      • 10.4.9 Singapore Blood Glucose Device Consumption (2017-2022)

      • 10.4.10 Malaysia Blood Glucose Device Consumption (2017-2022)

      • 10.4.11 Philippines Blood Glucose Device Consumption (2017-2022)

      • 10.4.12 Vietnam Blood Glucose Device Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Blood Glucose Device Consumption (2017-2022)

      • 10.5.2 Colombia Blood Glucose Device Consumption (2017-2022)

      • 10.5.3 Chile Blood Glucose Device Consumption (2017-2022)

      • 10.5.4 Argentina Blood Glucose Device Consumption (2017-2022)

      • 10.5.5 Venezuela Blood Glucose Device Consumption (2017-2022)

      • 10.5.6 Peru Blood Glucose Device Consumption (2017-2022)

      • 10.5.7 Puerto Rico Blood Glucose Device Consumption (2017-2022)

      • 10.5.8 Ecuador Blood Glucose Device Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Blood Glucose Device Consumption (2017-2022)

      • 10.6.2 Kuwait Blood Glucose Device Consumption (2017-2022)

      • 10.6.3 Oman Blood Glucose Device Consumption (2017-2022)

      • 10.6.4 Qatar Blood Glucose Device Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Blood Glucose Device Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Blood Glucose Device Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Blood Glucose Device Consumption (2017-2022)

      • 10.7.2 South Africa Blood Glucose Device Consumption (2017-2022)

      • 10.7.3 Egypt Blood Glucose Device Consumption (2017-2022)

      • 10.7.4 Algeria Blood Glucose Device Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Blood Glucose Device Consumption (2017-2022)

      • 10.8.2 New Zealand Blood Glucose Device Consumption (2017-2022)

    11 Global Blood Glucose Device Competitive Analysis

    • 11.1 Johnson & Johnson (US)

      • 11.1.1 Johnson & Johnson (US) Company Details

      • 11.1.2 Johnson & Johnson (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson (US) Blood Glucose Device Main Business and Markets Served

      • 11.1.4 Johnson & Johnson (US) Blood Glucose Device Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 ARKRAY (Japan)

      • 11.2.1 ARKRAY (Japan) Company Details

      • 11.2.2 ARKRAY (Japan) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 ARKRAY (Japan) Blood Glucose Device Main Business and Markets Served

      • 11.2.4 ARKRAY (Japan) Blood Glucose Device Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 FHoffmann-La Roche Ltd (Switzerland)

      • 11.3.1 FHoffmann-La Roche Ltd (Switzerland) Company Details

      • 11.3.2 FHoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 FHoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Main Business and Markets Served

      • 11.3.4 FHoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Dexcom (US)

      • 11.4.1 Dexcom (US) Company Details

      • 11.4.2 Dexcom (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Dexcom (US) Blood Glucose Device Main Business and Markets Served

      • 11.4.4 Dexcom (US) Blood Glucose Device Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Abbott Laboratories (US)

      • 11.5.1 Abbott Laboratories (US) Company Details

      • 11.5.2 Abbott Laboratories (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Abbott Laboratories (US) Blood Glucose Device Main Business and Markets Served

      • 11.5.4 Abbott Laboratories (US) Blood Glucose Device Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Terumo Medical Corporation (US)

      • 11.6.1 Terumo Medical Corporation (US) Company Details

      • 11.6.2 Terumo Medical Corporation (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Terumo Medical Corporation (US) Blood Glucose Device Main Business and Markets Served

      • 11.6.4 Terumo Medical Corporation (US) Blood Glucose Device Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Medtronic (US)

      • 11.7.1 Medtronic (US) Company Details

      • 11.7.2 Medtronic (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Medtronic (US) Blood Glucose Device Main Business and Markets Served

      • 11.7.4 Medtronic (US) Blood Glucose Device Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Nipro Diagnostics (US)

      • 11.8.1 Nipro Diagnostics (US) Company Details

      • 11.8.2 Nipro Diagnostics (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Nipro Diagnostics (US) Blood Glucose Device Main Business and Markets Served

      • 11.8.4 Nipro Diagnostics (US) Blood Glucose Device Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Blood Glucose Device Market Outlook by Types and Applications to 2028

    • 12.1 Global Blood Glucose Device Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Blood Glucose Monitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Glucose Monitoring Strips Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Lancets Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Blood Glucose Device Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Home Settings Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Blood Glucose Device Market Analysis and Outlook to 2028

    • 13.1 Global Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.2.2 Canada Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.2 UK Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.3 Spain Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.5 France Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.6 Italy Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.8 Finland Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.9 Norway Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.11 Poland Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.12 Russia Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.2 Japan Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.3 India Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.3 Chile Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.6 Peru Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.6.3 Oman Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Blood Glucose Device Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Blood Glucose Device Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Blood Glucose Device Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Blood Glucose Device

    • Figure of Blood Glucose Device Picture

    • Table Global Blood Glucose Device Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Blood Glucose Device Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Blood Glucose Monitors Consumption and Growth Rate (2017-2022)

    • Figure Global Glucose Monitoring Strips Consumption and Growth Rate (2017-2022)

    • Figure Global Lancets Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Home Settings Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Glucose Device Consumption by Country (2017-2022)

    • Table North America Blood Glucose Device Consumption by Country (2017-2022)

    • Figure United States Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Canada Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Mexico Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table Europe Blood Glucose Device Consumption by Country (2017-2022)

    • Figure Germany Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure UK Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Spain Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Belgium Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure France Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Italy Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Denmark Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Finland Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Norway Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Sweden Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Poland Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Russia Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Turkey Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table APAC Blood Glucose Device Consumption by Country (2017-2022)

    • Figure China Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Japan Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure India Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure South Korea Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Thailand Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Singapore Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Philippines Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table South America Blood Glucose Device Consumption by Country (2017-2022)

    • Figure Brazil Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Colombia Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Chile Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Argentina Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Peru Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table GCC Blood Glucose Device Consumption by Country (2017-2022)

    • Figure Bahrain Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Oman Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Qatar Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table Africa Blood Glucose Device Consumption by Country (2017-2022)

    • Figure Nigeria Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure South Africa Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Egypt Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure Algeria Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table Oceania Blood Glucose Device Consumption by Country (2017-2022)

    • Figure Australia Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Blood Glucose Device Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson (US) Company Details

    • Table Johnson & Johnson (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (US) Blood Glucose Device Main Business and Markets Served

    • Table Johnson & Johnson (US) Blood Glucose Device Product Portfolio

    • Table ARKRAY (Japan) Company Details

    • Table ARKRAY (Japan) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table ARKRAY (Japan) Blood Glucose Device Main Business and Markets Served

    • Table ARKRAY (Japan) Blood Glucose Device Product Portfolio

    • Table FHoffmann-La Roche Ltd (Switzerland) Company Details

    • Table FHoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table FHoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Main Business and Markets Served

    • Table FHoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Portfolio

    • Table Dexcom (US) Company Details

    • Table Dexcom (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dexcom (US) Blood Glucose Device Main Business and Markets Served

    • Table Dexcom (US) Blood Glucose Device Product Portfolio

    • Table Abbott Laboratories (US) Company Details

    • Table Abbott Laboratories (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories (US) Blood Glucose Device Main Business and Markets Served

    • Table Abbott Laboratories (US) Blood Glucose Device Product Portfolio

    • Table Terumo Medical Corporation (US) Company Details

    • Table Terumo Medical Corporation (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Medical Corporation (US) Blood Glucose Device Main Business and Markets Served

    • Table Terumo Medical Corporation (US) Blood Glucose Device Product Portfolio

    • Table Medtronic (US) Company Details

    • Table Medtronic (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic (US) Blood Glucose Device Main Business and Markets Served

    • Table Medtronic (US) Blood Glucose Device Product Portfolio

    • Table Nipro Diagnostics (US) Company Details

    • Table Nipro Diagnostics (US) Blood Glucose Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nipro Diagnostics (US) Blood Glucose Device Main Business and Markets Served

    • Table Nipro Diagnostics (US) Blood Glucose Device Product Portfolio

    • Figure Global Blood Glucose Monitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glucose Monitoring Strips Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lancets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Settings Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Table North America Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure United States Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure Germany Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure China Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure Brazil Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Blood Glucose Device Consumption Forecast by Country (2022-2028)

    • Figure Australia Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Blood Glucose Device Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US